Randomized Trial of Prasugrel Plus Bivalirudin vs. Clopidogrel Plus Heparin in Patients With Acute STEMI.

Trial Profile

Randomized Trial of Prasugrel Plus Bivalirudin vs. Clopidogrel Plus Heparin in Patients With Acute STEMI.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2016

At a glance

  • Drugs Bivalirudin (Primary) ; Prasugrel (Primary) ; Clopidogrel; Heparin
  • Indications Myocardial infarction
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BRAVE-4
  • Most Recent Events

    • 21 Jan 2014 Planned End Date changed from 1 Jul 2013 to 1 Feb 2015 according to ClinicalTrials.gov record.
    • 21 Jan 2014 Status changed from recruiting to active, no longer recruiting; according to ClinicalTrials.gov record.
    • 18 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top